Article: [Hospitalization of young women after selected cardiovascular and thromboembolic incidents in Austria 1993 and 1994]

The aim of this study is to describe the hospitalization and regional distribution of selected cardiovascular and thrombo-embolic events (cardiac infarction, cerebral strokes, deep vein thromboses, pulmonary embolism) of young women in Austria in the years 1993 and 1994, and to collect basic epidemiologic data for the study of the side effects of oral contraceptives. The calculated hospitalization rates are based on the Austrian hospitals' discharge records of 1993 and 1994. The persons concerned are women aged between 15 and 44 who live in Austria. The results of the study reveal that--in 1993--of the above mentioned group 51 out of 100,000 inhabitants were hospitalized because of the selected cardiovascular and thromboembolic events: 4/100,000 had a cardiac infarction, 5/100,000 had a stroke, 17/100,000 had a pulmonary embolism, and 27/100,000 suffered a deep vein thrombosis. In 1994 the counted cases per 100,000 inhabitants were 48, out of which 4/100,000 where cardiac infarcts, 5/100,000 strokes, 16/100,000 pulmonary embolism, and 25/100,000 deep vein thromboses.

Citing Articles

Combined oral contraceptives: venous thrombosis.

de Bastos M, Stegeman B, Rosendaal F, van Hylckama Vlieg A, Helmerhorst F, Stijnen T Cochrane Database Syst Rev. 2014; (3):CD010813.

PMID: 24590565 PMC: 10637279. DOI: 10.1002/14651858.CD010813.pub2.

References

1.

Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T . A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med. 1992; 232(2):155-60. DOI: 10.1111/j.1365-2796.1992.tb00565.x. View

2.

Anderson Jr F, Wheeler H, Goldberg R, Hosmer D, Patwardhan N, Jovanovic B . A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991; 151(5):933-8. View

3.

. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet. 1995; 346(8990):1575-82. View

4.

. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet. 1995; 346(8990):1582-8. View

5.

Jick H, Jick S, Gurewich V, Myers M, Vasilakis C . Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet. 1995; 346(8990):1589-93. DOI: 10.1016/s0140-6736(95)91928-7. View

6.

Bloemenkamp K, Rosendaal F, Helmerhorst F, Buller H, Vandenbroucke J . Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet. 1995; 346(8990):1593-6. DOI: 10.1016/s0140-6736(95)91929-5. View

7.

Eisenblatter D, Heinemann L, Classen E . Community-based stroke incidence trends from the 1970s through the 1980s in East Germany. Stroke. 1995; 26(6):919-23. DOI: 10.1161/01.str.26.6.919. View

8.

Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas A, Schroll M . Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease. Stroke. 1995; 26(3):361-7. DOI: 10.1161/01.str.26.3.361. View

9.

Spitzer W, Lewis M, Heinemann L, Thorogood M, MacRae K . Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ. 1996; 312(7023):83-8. PMC: 2349742. DOI: 10.1136/bmj.312.7023.83. View

10.

Lewis M, Spitzer W, Heinemann L, MacRae K, Bruppacher R, Thorogood M . Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ. 1996; 312(7023):88-90. PMC: 2349749. DOI: 10.1136/bmj.312.7023.88. View

[Hospitalization of Young Women After Selected Cardiovascular and Thromboembolic Incidents in Austria 1993 and 1994]